The MDXG chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the MDXG chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The MDXG stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View MDXG Detailed Price Forecast - CNN Money||View MDXG Detailed Summary - Google Finance|
|View MDXG Detailed Summary - Yahoo! Finance||View MDXG Stock Research & Analysis - Zacks.com|
|View MDXG Trends & Analysis - Trade-Ideas||View MDXG Major Holders - Barrons|
|View MDXG Call Transcripts - NASDAQ||View MDXG Breaking News & Analysis - Seeking Alpha|
|View MDXG Annual Report - CompanySpotlight.com||View MDXG OTC Short Report - OTCShortReport.com|
|View MDXG Fundamentals - TradeKing||View MDXG SEC Filings - Bar Chart|
|View Historical Prices for MDXG - The WSJ||View Performance/Total Return for MDXG - Morningstar|
|View the Analyst Estimates for MDXG - MarketWatch||View the Earnings History for MDXG - CNBC|
|View the MDXG Earnings - StockMarketWatch||View MDXG Buy or Sell Recommendations - MacroAxis|
|View the MDXG Bullish Patterns - American Bulls||View MDXG Short Pain Metrics - ShortPainBot.com|
|View MDXG Stock Mentions - StockTwits||View MDXG Stock Mentions - PennyStockTweets|
|View MDXG Stock Mentions - Twitter||View MDXG Investment Forum News - Investor Hub|
|View MDXG Stock Mentions - Yahoo! Message Board||View MDXG Stock Mentions - Seeking Alpha|
|View Insider Transactions for MDXG - SECform4.com||View Insider Transactions for MDXG - Insider Cow|
|View MDXG Major Holdings Summary - CNBC||View Insider Disclosure for MDXG - OTC Markets|
|View Insider Transactions for MDXG - Yahoo! Finance||View Institutional Holdings for MDXG - NASDAQ|
|View MDXG Stock Insight & Charts - FinViz.com||View MDXG Investment Charts - StockCharts.com|
|View MDXG Stock Overview & Charts - BarChart||View MDXG User Generated Charts - Trading View|
Short-Selling Is Really Hard. Just Ask Citron Research
Posted on Friday February 22, 2019
Examining the influential short-sellers' big winners and losers provides important insights into trading and investing.
[$$] Sen. Johnny Isakson Called FBI on Behalf of MiMedx Group
Posted on Thursday December 27, 2018
Sen. Johnny Isakson, a Georgia Republican, called the Federal Bureau of Investigation in October 2017 to follow up on a complaint lodged by Parker “Pete” Petit, the founder of biomedical company MiMedx Group against an investor who criticized the company and Mr. Petit. Mr. Petit had complained to the FBI and Mr. Isakson called the FBI to ask that they respond to the complaint, his spokeswoman confirmed, adding that Mr. Isakson didn’t request a specific outcome. Seven weeks later, the investor, Marc Cohodes, received a visit from two FBI agents who told him that if he didn’t stop posting negative tweets about Mr. Petit and MiMedx, “there would be consequences,” he told The Wall Street Journal.
Today's Research Reports on Trending Tickers: MiMedx Group and Tandem Diabetes Care
Posted on Wednesday December 12, 2018
NEW YORK, NY / ACCESSWIRE / December 12, 2018 / U.S. equities finished lower on Tuesday after bouncing between the red and green territory. The stocks gained more than 1% across the board on improving ...
MiMedx Announces Resignation Of Outside Auditor
Posted on Wednesday December 05, 2018
MARIETTA, Ga., Dec. 5, 2018 /PRNewswire/ -- MiMedx Group, Inc. (OTC PINK: MDXG), a leading developer and marketer of regenerative and therapeutic biologics, today announced that on December 4, 2018, Ernst & Young LLP informed the Company's Audit Committee that it has resigned from the engagement to audit the Company's financial statements for the years ended December 31, 2017 and 2018, effective immediately. MiMedx® is a leading biopharmaceutical company developing and marketing regenerative and therapeutic biologics utilizing human placental tissue allografts with patent-protected processes for multiple sectors of healthcare. The Company processes the human placental tissue utilizing its proprietary PURION® process methodology, among other processes, to produce allografts by employing aseptic processing techniques in addition to terminal sterilization.